Triggers of apoptosis in the immature brain

Brain and Development

Volumn 31, Issue 7, 2009, Pages 488-492

  Ikonomidou, Chrysanthy ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Antiepileptic drugs; Development; Oxygen; Sedative drugs

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALCOHOL; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DIAZEPAM; DIZOCILPINE; KETAMINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTROPHIN; NITROUS OXIDE; PHENOBARBITAL; PHENYTOIN; PROPOFOL; SEDATIVE AGENT; SULTIAME; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; VOLTAGE GATED SODIUM CHANNEL;

APOPTOSIS; BRAIN DEVELOPMENT; BRAIN GROWTH; CELL PROLIFERATION; COGNITIVE DEFECT; DRUG BLOOD LEVEL; FETOTOXICITY; HUMAN; HYPEROXIA; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRENATAL DRUG EXPOSURE; REVIEW; SEIZURE; SYNAPTOGENESIS;

ANIMALS; ANTICONVULSANTS; APOPTOSIS; BRAIN; CELL PROLIFERATION; CYTOKINES; ENVIRONMENT; ETHANOL; HUMANS; HYPNOTICS AND SEDATIVES; NERVE DEGENERATION; NERVE GROWTH FACTORS; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXYGEN; RECEPTORS, GABA-A; RECEPTORS, N-METHYL-D-ASPARTATE; SODIUM CHANNEL BLOCKERS;

EID: 67649429443     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2009.02.006     Document Type: Review

References (20)

1. Ishimaru M.J., Ikonomidou C., Tenkova T.I., Der T.C., Dikranian K., Sesma M.A., et al. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol 408 (1999) 461-476
2. Dikranian K., Ishimaru M.J., Tenkova T., Labruyere J., Qin Y.Q., Ikonomidou C., et al. Apoptosis in the in vivo mammalian forebrain. Neurobiol Dis 8 (2001) 359-379
3. Bittigau P., Sifringer M., Genz K., Reith E., Pospischil D., Govindarajalu S., et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 99 (2002) 15089-15094
4. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vöckler J., Dikranian K., et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283 (1999) 70-74
5. Ikonomidou C., Bittigau P., Ishimaru M.J., Wozniak D.F., Koch C., Genz K., et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287 (2000) 1056-1060
6. Jevtovic-Todorovic V., Hartman R.E., Izumi Y., Benshoff N.D., Dikranian K., and Zorumski C.F. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 23 (2003) 876-882
7. Dobbing J., and Sands J. Quantitative growth and development of human brain. Arch Dis Child 48 (1993) 757-767
8. Glier C., Dzietko M., Bittigau P., Jarosz B., Korobowicz E., and Ikonomidou C. Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol 185 (2004) 403-409
9. Manthey D., Asimiadou S., Stefovska V., Kaindl A.M., Fassbender J., Ikonomidou C., et al. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol 93 (2005) 497-503
10. Hansen H.H., Briem T., Dzietko M., Sifringer M., Voss A., Rzeski W., et al. Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain. Neurobiol Dis 16 (2004) 440-453
11. Asimiadou S., Bittigau P., Felderhoff-Mueser U., Manthey D., Sifringer M., Pesditschek S., et al. Protection with estradiol in developmental models of apoptotic neurodegeneration. Ann Neurol 58 (2005) 266-276
12. Hansen H.H., Krutz B., Sifringer M., Stefovska V., Bittigau P., Pragst F., et al. Cannabinoids enhance susceptibility of immature brain to ethanol neurotoxicity. Ann Neurol 64 (2008) 42-52
13. Papadia S., Soriano F.X., Léveillé F., Martel M.A., Dakin K.A., Hansen H.H., et al. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci 11 (2008) 476-487
14. Ikonomidou C., Scheer J., Wilhelm T., Juengling F., Titze K., Stöver B., et al. Brain morphology alterations in the basal ganglia and the hypothalamus following prenatal exposure to antiepileptic drugs. Eur J Ped Neurol 11 (2007) 297-301
15. Barr H.M., and Streissguth A.P. Identifying maternal self-reported alcohol use associated with fetal alcohol spectrum disorders. Alcohol Clin Exp Res 25 (2001) 283-287
16. Olney J.W., Young C., Wozniak D.F., Jevtovic-Todorovic V., and Ikonomidou C. Do pediatric drugs cause developing neurons to commit suicide?. Trends Pharmacol Sci 25 (2004) 135-139
17. Felderhoff-Mueser U., Bittigau P., Sifringer M., Jarosz B., Korobowicz E., Mahler L., et al. Oxygen causes cell death in the developing brain. Neurobiol Dis 17 (2004) 273-282
18. Felderhoff-Mueser U., Sifringer M., Polley O., Dzietko M., Leineweber B., Mahler L., et al. Caspase-1-processed interleukins in hyperoxia-induced cell death in the developing brain. Ann Neurol 57 (2005) 50-59
19. Kaindl A.M., Sifringer M., Zabel C., Nebrich G., Wacker M., Felderhoff-Mueser U., et al. Acute and long-term proteome changes induced by oxidative stress in the developing brain. Cell Death Diff 13 (2006) 1097-1109
20. Stefovska V., Czuczwar M., Smitka M., Czuczwar P., Kis J., Kaindl A.M., et al. Sedative and anticonvulsant drugs suppress postnatal neurogenesis. Ann Neurol 64 (2008) 434-445